voriconazole has been researched along with Hematologic Diseases in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 16 (69.57) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YH; Su, PX | 1 |
| Abad-Santos, F; Antón, C; Borobia, AM; Bueno, D; Carcas, A; de la Cámara, R; Estébanez, M; Frías Iniesta, J; García García, I; López de la Guía, A; Mejía, G; Monserrat Villatoro, J; Otero, MJ; Ramírez García, E | 1 |
| Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF | 1 |
| Dryś, A; Dybko, J; Hurkacz, M; Sienkiewicz, B; Urbaniak-Kujda, D; Wiela-Hojeńska, A; Wróbel, T | 1 |
| Annino, L; Arcioni, F; Barberi, W; Bertaina, A; Carotti, A; Cartoni, C; Caselli, D; Cassetta, MI; Cerchiara, E; Cupelli, L; Fallani, S; Fanci, R; Ferrari, A; Girardi, K; Girmenia, C; Marchesi, F; Mariotti, B; Novelli, A; Proia, A; Ribersani, M; Venditti, A | 1 |
| Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A | 1 |
| Fukuoka, N; Imataki, O; Uemura, M; Yamaguchi, K | 1 |
| Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH | 1 |
| He, S; Huang, J; Jiang, H; Lu, X; Mafuru, M; Wu, S | 1 |
| Araoka, H; Asano-Mori, Y; Hayashi, M; Ishiwata, K; Ito, T; Izutsu, K; Kaji, D; Makino, S; Masuoka, K; Matsuno, N; Nishida, A; Ota, H; Takagi, S; Taniguchi, S; Tsuji, M; Uchida, N; Uchida, Y; Wake, A; Yamamoto, G; Yamamoto, H; Yoneyama, A | 1 |
| Tang, S | 1 |
| Barrueta, JA; Charbonneau, C; De Salas-Cansado, M; Gao, X; Garcia-Vidal, C; Jarque, I; Ostermann, H; Solano, C; Stephens, J; Weber, B; Xue, M | 1 |
| Akahoshi, Y; Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, SI; Murata, T; Nakano, H; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Tanihara, A; Terasako-Saito, K; Ugai, T; Wada, H; Yamasaki, R; Yamazaki, R | 1 |
| Akagi, T; Ishida, Y; Ito, S; Kowata, S; Kubo, K; Murai, K; Oyake, T; Sawada, K | 1 |
| Buchheidt, D; Christopeit, M; Hähnel, S; Heinz, W; Maschmeyer, G; Meyding-Lamadé, U; Panse, J; Penack, O; Ruhnke, M; Schalk, E; Schmidt-Hieber, M; Schwartz, S; Silling, G; Wolf, HH | 1 |
| Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A | 1 |
| Arda, B; Ceylan, N; Erdem, A; Işıkgöz Taşbakan, M; Metin, DY; Midilli, R; Pullukçu, H; Sipahi, OR; Taşbakan, MS; Ulusoy, S; Yamazhan, T | 1 |
| Buresova, L; Cetkovsky, P; Kocmanova, I; Kouba, M; Lengerova, M; Malaskova, L; Mayer, J; Racil, Z; Rolencova, M; Timilsina, S; Toskova, M; Weinbergerova, B; Winterova, J; Zak, P | 1 |
| Egerer, G | 1 |
| Bennett, JE; Caillot, D; Chandrasekar, PH; de Pauw, B; Denning, DW; Durand, C; Greene, RE; Herbrecht, R; Hodges, MR; Kern, WV; Lortholary, O; Marr, KA; Oestmann, JW; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Stark, P; Sylvester, R; Thiel, E; Troke, PF; Wingard, JR | 1 |
| Chevallier, P; Dubruille, V; Guillaume, T; Harousseau, JL; Mahé, B; Méchinaud, F; Milpied, N; Moreau, P; Morin, O; Morineau, N; Vigouroux, S | 1 |
| de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C | 1 |
| Jarque, I; Sanz, MA | 1 |
2 review(s) available for voriconazole and Hematologic Diseases
| Article | Year |
|---|---|
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole | 2020 |
[Current indications for voriconazole in onco-hematological patients].
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis | 2007 |
3 trial(s) available for voriconazole and Hematologic Diseases
| Article | Year |
|---|---|
Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Echinocandins; Febrile Neutropenia; Female; Hematologic Diseases; Hematologic Neoplasms; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2016 |
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole | 2012 |
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2002 |
18 other study(ies) available for voriconazole and Hematologic Diseases
| Article | Year |
|---|---|
[Value of the Diagnostic-Driven Therapy with Voriconazole in Patients with Hematological Disorders Complicated by Invasive Fungal Disease].
Topics: Antifungal Agents; Hematologic Diseases; Humans; Invasive Fungal Infections; Retrospective Studies; Voriconazole | 2022 |
Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol.
Topics: Aspergillosis; Genotype; Hematologic Diseases; Humans; Multicenter Studies as Topic; Pharmacogenetics; Voriconazole | 2020 |
Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT.
Topics: Biomarkers, Tumor; Cohort Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A Inhibitors; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Genotype; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Polymorphism, Genetic; Prognosis; Transplantation, Homologous; Voriconazole | 2018 |
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?
Topics: Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Child; Child, Preschool; Female; Hematologic Diseases; Humans; Infant; Male; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biological Variation, Population; Comorbidity; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Voriconazole | 2018 |
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Male; Mycoses; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Voriconazole | 2019 |
The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders.
Topics: Adult; Antifungal Agents; Cytokines; Drug Monitoring; Female; Hematologic Diseases; Humans; Inflammation; Male; Retrospective Studies; Voriconazole | 2019 |
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Cord Blood Stem Cell Transplantation; Drug Interactions; Female; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Premedication; Prospective Studies; Risk Factors; Transplantation Conditioning; Vidarabine; Voriconazole; Young Adult | 2014 |
[Treatment recommendations for invasive fungal disease in pediatric patients with cancer or blood disease].
Topics: Antifungal Agents; Candidiasis; Caspofungin; Child; Echinocandins; Hematologic Diseases; Humans; Lipopeptides; Mycoses; Neoplasms; Pediatrics; Practice Guidelines as Topic; Voriconazole | 2014 |
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Costs and Cost Analysis; Germany; Hematologic Diseases; Spain; Voriconazole | 2014 |
Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases.
Topics: Antifungal Agents; Chemoprevention; Clinical Trials as Topic; Cost-Benefit Analysis; Diagnostic Tests, Routine; Echinocandins; Hematologic Diseases; Humans; Lipopeptides; Micafungin; Mycoses; Neutropenia; Retrospective Studies; Voriconazole | 2015 |
CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Topics: Central Nervous System; Communicable Diseases; Germany; Guidelines as Topic; Hematologic Diseases; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Medical Oncology; Toxoplasma; Voriconazole | 2016 |
[Mucormycosis: retrospective evaluation of 12 cases].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Female; Hematologic Diseases; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Nose Diseases; Orbital Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hematologic Diseases; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
Topics: Absidia; Adult; Antifungal Agents; Child, Preschool; Female; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizomucor; Rhizopus; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |